Literature DB >> 30503943

Carbohydrate-naphthalene diimide conjugates as potential antiparasitic drugs: Synthesis, evaluation and structure-activity studies.

M Zuffo1, A Stucchi1, J Campos-Salinas2, M Cabello-Donayre2, M Martínez-García2, E Belmonte-Reche2, J M Pérez-Victoria2, J L Mergny3, M Freccero1, J C Morales2, F Doria4.   

Abstract

The neglected tropical diseases Human African Trypanosomiasis and leishmaniasis are caused by infection with trypanosomatid parasites Trypanosoma brucei and Leishmania spp, respectively. The genomes of these organisms contain multiple putative G-quadruplex (G4) forming sequences which have recently been proposed to mediate processes relevant for parasite survival. Therefore, G4 could be considered as potential targets for a novel approach towards the development of antiparasitic drugs. Recently, we have demonstrated that G4 ligands such as carbohydrate naphthalene diimide conjugates (carb-NDIs) possess notable antiparasitic activity. Herein, we have synthesized a new family of carb-NDIs, characterized by significant structural variability, and evaluated their anti-parasitic activity, with special focus on T. brucei. The interaction with relevant G4 sequences was evaluated in vitro through independent biophysical methods (FRET melting assays under competing conditions with double stranded DNA, circular dichroism and fluorescence titrations). Finally, flow cytometry and confocal microscopy experiments demonstrated that the conjugates exhibit excellent uptake into T. brucei parasites, localizing in the nuclei and kinetoplasts. Promising antiparasitic activity and selectivity against control mammalian cells, together with their peculiar mechanism of action, render the carb-NDI conjugates as suitable candidates for the development of an innovative treatment of trypanosomiasis.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiparasitic activity; G-quadruplex (G4); Naphthalene diimide; Trypanosoma brucei

Mesh:

Substances:

Year:  2018        PMID: 30503943     DOI: 10.1016/j.ejmech.2018.11.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

Review 1.  Iron and Heme Metabolism at the Leishmania-Host Interface.

Authors:  Maria Fernanda Laranjeira-Silva; Iqbal Hamza; José M Pérez-Victoria
Journal:  Trends Parasitol       Date:  2020-01-28

2.  Stiff-Stilbene Ligands Target G-Quadruplex DNA and Exhibit Selective Anticancer and Antiparasitic Activity.

Authors:  Michael P O'Hagan; Pablo Peñalver; Rosina S L Gibson; Juan C Morales; M Carmen Galan
Journal:  Chemistry       Date:  2020-04-28       Impact factor: 5.236

3.  Identifying and validating the presence of Guanine-Quadruplexes (G4) within the blood fluke parasite Schistosoma mansoni.

Authors:  Holly M Craven; Riccardo Bonsignore; Vasilis Lenis; Nicolo Santi; Daniel Berrar; Martin Swain; Helen Whiteland; Angela Casini; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2021-02-18

Review 4.  The Current Directions of Searching for Antiparasitic Drugs.

Authors:  Katarzyna Dziduch; Dominika Greniuk; Monika Wujec
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

5.  G-Quadruplex DNA as a Target in Pathogenic Bacteria: Efficacy of an Extended Naphthalene Diimide Ligand and Its Mode of Action.

Authors:  Rubén Cebrián; Efres Belmonte-Reche; Valentina Pirota; Anne de Jong; Juan Carlos Morales; Mauro Freccero; Filippo Doria; Oscar P Kuipers
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

Review 6.  Naphthalene Diimides as Multimodal G-Quadruplex-Selective Ligands.

Authors:  Valentina Pirota; Matteo Nadai; Filippo Doria; Sara N Richter
Journal:  Molecules       Date:  2019-01-24       Impact factor: 4.411

7.  Trifunctionalized Naphthalene Diimides and Dimeric Analogues as G-Quadruplex-Targeting Anticancer Agents Selected by Affinity Chromatography.

Authors:  Chiara Platella; Valentina Pirota; Domenica Musumeci; Federica Rizzi; Sara Iachettini; Pasquale Zizza; Annamaria Biroccio; Mauro Freccero; Daniela Montesarchio; Filippo Doria
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.